TEL-AVIV, Israel, May 10, 2016 /PRNewswire/ -- 2breathe Technologies Ltd., a pioneer in developing digital therapeutic devices, today announced that 2breathe™, a new smart, connected device tackling sleeplessness via a patented guided-breathing technology, is now publicly available. The new product, will be showcased at Israel's premier health and life sciences industry event IATI-BIOMED on May 26, 2016.
2breathe broadly-patented technology grew out of a FDA-cleared device for non-drug treatment of hypertension and stress, RESPeRATE, used by hundreds of thousands of doctors and patients. RESPeRATE's one "side effect" was that users reported dozing off during the session and improved sleep. The Company adapted the technology for smartphones and created the 2breathe platform to induce sleep.
2breathe uses smart, connected technology to deliver the ancient wisdom of sleep-inducing breathing exercises in an easy and effective manner. A sensor worn around the torso picks up the user's inhale and exhale movements sending it to an iOS app via low energy Bluetooth. The app transforms, in real time, the breathing into tones that gradually guide the user to prolonged exhalation and slow breathing. Within minutes, neural sympathetic activity is reduced, the user begins to disassociate from both external and internal stimuli, and the mind and body relax into sleep. Once sleep is detected, 2breathe automatically shuts off and generates a report showing the falling asleep process breath-by-breath.
"We believe that tracking sleep is nice, but inducing sleep is better," said Erez Gavish, Co-Founder and CEO. "164 million Americans struggle with sleep at least once a week which is not surprising considering the extent of modern day work schedules and life stresses. We're excited to be able to offer a real breakthrough to help those who can not 'shut off' their minds and fall asleep."
About 2breathe Technologies Ltd.
2breathe Technologies Ltd. (www.2breathe.com) and its founders are pioneers in the development of the digital therapeutic devices field, first in hypertension and now in sleeplessness. The original product, RESPeRATE® (www.resperate.com), is the world's first FDA-cleared, non-drug hypertension treatment device now used by hundreds of thousands of patients and featured in the American Heart Association statement on non-pharmacological treatments. The new product, 2breathe™, adopts RESPeRATE guided-breathing technology for individuals who have difficulties falling asleep. 2breathe is not a medical device and is not intended to diagnose or treat medical conditions. For additional information, please visit www.2breathe.com.
Co-Founder & CEO
SOURCE 2breathe Technologies Ltd